✦ LIBER ✦

Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey

✍ Scribed by Cristina Masini; Roberto Sabbatini; Camillo Porta; Giuseppe Procopio; Giuseppe Di Lorenzo; Azzurra Onofri; Sebastiano Buti; Roberto Iacovelli; Roberta Invernizzi; Luca Moscetti; Maria Giuseppina Aste; Maria Pagano; Federica Grosso; Anna Lucia Manenti; Cinzia Ortega; Laura Cosmai; Cinzia Del Giovane; Pier Franco Conte

Book ID: 115199532
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 225 KB
Volume: 110
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2012.10946.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tyrosine kinase inhibitor treatments in

Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network

✍ Massicotte, M.-H.; Brassard, M.; Claude-Desroches, M.; Borget, I.; Bonichon, F.; 📂 Article 📅 2014 🏛 Bioscientifica 🌐 English ⚖ 159 KB

Efficacy of the tyrosine kinase inhibito

Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer

✍ Araki, Jun; Okamoto, Isamu; Suto, Ryuichiro; Ichikawa, Yasuko; Sasaki, Ji-ichiro 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 215 KB

A multicenter phase II study of TSU-68,

A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance

✍ Masakazu Toi, Toshiaki Saeki, Hiroji Iwata, Kenichi Inoue, Yutaka Tokuda… 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 235 KB

A randomized, phase II, dose-finding stu

A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer

✍ Olivier Rixe; Sandra X. Franco; Denise A. Yardley; Stephen R. Johnston; Miguel M 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 367 KB

A Phase II Safety and Efficacy Study of

A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer

✍ Pili, Roberto; Qin, Rui; Flynn, P.J.; Picus, Joel; Millward, Michael; Ho, Wing M 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 791 KB

Prolonged use of the tyrosine kinase inh

Prolonged use of the tyrosine kinase inhibitor in a peritoneal dialysis patient with metastatic renal cell carcinoma: possible beneficial effects on peritoneal membrane and peritonitis rates

✍ Shruti N. Tapiawala; Joanne M. Bargman; Dimitrios G. Oreopoulos; Martin Simons 📂 Article 📅 2009 🏛 Springer Netherlands 🌐 English ⚖ 137 KB